body { -epub-hyphens:auto; } /* h2 { margin-top:40px; } */ /* h2 + p + p { margin-top: 12px !important; } */ h3 {ce_credit margin-top:1.5em; margin-bottom:.75em; } h4:nth-child(n + 2) { margin-top:40px; } p.date { -epub-hyphens:none; color:#0078b9; font-family:"freight-sans-pro", sans-serif; font-size:18px; font-style:normal; font-variant:normal; font-weight:bold; line-height:1; margin-bottom:2px; margin-left:0; margin-right:0; margin-top:0; orphans:1; page-break-after:auto; pag

The Robert K. Chalmers Distinguished Pharmacy Educator Award is named for the late Robert K. Chalmers, former AACP president and distinguished educator and recognizes excellence in pharmacy education. The award recognizes an individual’s excellence in pharmacy education and consists of an inscribed glass sculpture and complimentary registration to the AACP Annual Meeting. Please contact Adam Jackson, AACP Director of Governance, with any questions.

Applications for the Robert K. Chalmers Distinguished Pharmacy Educator Award are due by 11:59 p.m. PST on Monday, December 1, 2025. Visit the application site to begin the submission process.

Eligibility

1. Nominees must hold a faculty appointment with a primary commitment to an AACP member college or school of pharmacy or be within five years of their full retirement from a faculty appointment.
2. Nominees must be members of AACP and have shown a commitment to the Association and mission and objectives of pharmacy education. A nominee’s name may not be submitted posthumously.
3. Nominees will be evaluated based upon contributions in the following areas:
   • Instruction including, but not limited to, effectiveness in undergraduate, post baccalaureate, professional and graduate instruction; curriculum development and innovation; special student educational projects; honors and awards for excellence in teaching and invited lectureships; and national educational involvement including active participation in AACP meetings, committees, teachers seminars and national workshops. Among the most important qualities are inspiration, leadership, and quality of contributions and the impact on educational programs and professional growth of individuals,
   • Research and Scholarly Activities relative to pharmacy education, which can be documented in terms of publications as well as invited presentations (teacher’s seminar, etc. e.g., curriculum development, evaluation instruments, and pedagogical methods). Quality of publications is of greater importance than quantity, and
   • Professional/Public Service and Outreach, including organized educational functions that combine knowledge and/or outreach activities of the school to practitioners and to society at large. Drug-related professional and lay public education should be recognized.
   • Impact on Pharmacy Education beyond one’s home institution, including evidence of positive change because of publications or professional involvement; accomplishments of former students and residents; recognition and awards from other educational institutions; and other contributions and activities that have a documented impact on pharmacy education.

AACP's AWARDS AND NOMINATIONS POLICY

Disclosure Required

AACP’s Board of Directors has adopted a policy affirming AACP’s right to grant, defer or decline to grant an honor or award, including a leadership position, to any person. AACP expects all recipients of honors and awards to embody the highest standards of professional and personal ethical behavior, therefore, AACP will not confer any honor, award or leadership position when, in its discretion, there has been a determination or credible question of unethical behavior. 

To implement this policy, AACP is instituting a disclosure process for nominees for the Robert K. Chalmers Award. The required disclosure form must be completed, signed and submitted by December 1 to disclosure@aacp.org.

Nomination Procedure

1. Nominations may be made by any AACP member and are encouraged from faculty members of colleges and schools of pharmacy and from all segments of the Association (e.g., sections, special interest groups, affiliate members).
2. The dossier’s contents shall include:
   • Cover letter from the nominator summarizing the nominee’s qualifications and commitment to the Association;
   • Résumé detailing education, appointments, activities, memberships, awards and honors, and other relevant data;
   • Summary of contributions to instruction;
   • Summary of contributions of research and scholarly activities relating to pharmacy education (a list of publications is not sufficient);
   • Summary of contributions to public/professional service and outreach relating to education;
   • Summary of impact of candidate contributions on pharmacy education, and
   • An additional three to five letters of support that reflect and are specifically related to the criteria, including those endorsements from individuals outside of the nominee’s home institution (supporting letters should interpret the impact that the nominee has had on his/her field and pharmacy education and provide evidence of contributions to instruction, research/scholarly activities in education, and professional/public service/outreach in education).
3. The dossier should be submitted online by 11:59 p.m. PST on the date of the submission deadline. Materials will then be reviewed by the selection committee once an initial screening is completed.

Questions regarding the nomination or submission process should contact Adam Jackson, AACP Director of Governance.

Selection Procedure

1. Dossiers will be screened for completeness by staff upon receipt. If time permits, staff will notify nominators of missing items. Applications that are incomplete at the deadline for submission will not be evaluated.
2. A Robert K. Chalmers Distinguished Pharmacy Educator Award Committee appointed by the AACP president will conduct peer review of nominations based upon the established criteria for the award.
3. At the conclusion of the evaluation process, the committee will forward one name to the AACP Board of Directors for ratification at its February meeting. In addition, the award committee will provide to the Board of Directors a short justification for the selected award recipient. The committee may recommend that the Award not be presented in any given year.

Past Award Recipients

2025 - Naser Zaki Alsharif, Ph.D.

2024 - Frank Romanelli, Pharm.D.

2023 - Adam M. Persky, Ph.D.

2022 - Cynthia Boyle, Pharm.D.

2021 - Brian Erstad, Pharm.D.

2020 - Gayle Brazeau, Ph.D.

2019 - Susan M. Meyer, Ph.D.

2018 - Melissa S. Medina, Ed.D.

2017 - S. William (Sandy) Zito, Ph.D.

2016 - Terry L. Schwinghammer, Pharm.D.

2015 - John E. Murphy, Pharm.D.

2014 - Robert L. Talbert, Pharm.D.

2013 - Mary Lynn McPherson, Pharm.D.

2012 - Jean M. Nappi, Pharm.D.

2011 - Robert S. Beardsley, Ph.D., R.Ph.

2010 - Mary Anne Koda-Kimble, Pharm.D.

2009 - Bruce A. Berger, Ph.D.

The Volwiler Research Achievement Award was established as the research prize in academic pharmacy to honor the late Ernest H. Volwiler, former president and research director of Abbott Laboratories. The intent of the Award is to recognize annually an individual within the ranks of pharmacy education recognized by his or her peers as one of the leading research workers in a given area of the pharmaceutical and clinical sciences, pharmacy practice and the social and administrative sciences, and for outstanding contributions to the respective disciplines. This award consists of a glass sculpture and complimentary registration to the AACP Annual Meeting.

Applications for the Volwiler Research Achievement Award are due by 11:59 p.m. PST on Monday, December 1, 2025. Visit the application site to begin the submission process.

ELIGIBILITY

1. Nominees must hold a faculty appointment with a primary commitment to an AACP member college or school of pharmacy or be within five years of their full retirement from a faculty appointment.
2. Nominees must be members of AACP, and have shown a commitment to the Association and mission and objectives of pharmacy education. A nominee’s name may not be submitted posthumously.
3. Nominations must indicate evidence of research and creative scholarship relative to the pharmaceutical and clinical sciences and pharmacy practice and the social and administrative sciences and will be evaluated based upon contributions in the following areas:
   • Evidence of research and creative scholarship relative to the respective discipline;
   • Impact on a specific area in the respective discipline and pharmaceutical education, in general, including the nominee’s home institution and beyond; and
   • Contributions to teaching at both the professional and the graduate student levels.

AACP's AWARDS AND NOMINATIONS POLICY

Disclosure Required

AACP’s Board of Directors has adopted a policy affirming AACP’s right to grant, defer or decline to grant an honor or award, including a leadership position, to any person. AACP expects all recipients of honors and awards to embody the highest standards of professional and personal ethical behavior, therefore, AACP will not confer any honor, award or leadership position when, in its discretion, there has been a determination or credible question of unethical behavior. 

To implement this policy, AACP is instituting a disclosure process for nominees for the Volwiler Research Achievement Award. The required disclosure form must be completed, signed and submitted by December 1 to disclosure@aacp.org.

NOMINATION PROCEDURE

1. Nominations may be made by any AACP member and are encouraged from faculty members of colleges of pharmacy and from all segments of the Association (e.g. sections, special interest groups, affiliate members).
2. The dossier’s contents shall include:
   • Cover letter from the nominator summarizing the nominee’s qualifications and commitment to the Association;
   • Résumé detailing education, appointments, activities, memberships, awards and honors and other relevant data;
   • A summary statement on behalf of the nominee which puts his or her major research and scholarly accomplishments into perspective in such a way that a person from another discipline can understand and appreciate the significance of the nominee’s contributions (this should not exceed two single spaced pages);
   • A summary of the nominee’s contributions to teaching at both the professional and graduate student levels;
   • Three publications representative of current research activity; and
   • Three to five letters of endorsement, in addition to the original nomination, focusing on the research and scholarly accomplishments of the nominee and the impact that the nominee has had on his or her field and pharmacy education. Two endorsements must come from persons outside the nominee’s home institution.
3. The dossier should be submitted online by 11:59 p.m. PST on the date of the submission deadline. Materials will then be reviewed by the selection committee once an initial screening is completed.

Questions regarding the nomination or submission process should contact Adam Jackson, AACP Director of Governance.

SELECTION PROCEDURE

1. Dossiers will be screened for completeness by staff upon receipt. If time permits, staff will notify nominators of missing items. Applications that are incomplete at the deadline for submission will not be evaluated.
2. A Volwiler Research Achievement Award Committee appointed by the AACP president will conduct peer review of nominations in light of the established criteria for the award.
3. At the conclusion of the evaluation process, the committee will forward one name to the AACP Board of Directors for ratification at its February meeting.  In addition, the award committee will provide to the Board of Directors a short justification for the selected award recipient. The committee may recommend that the Award not be presented in any given year.

Past Award Recipients

• 2025 - Alan J. Zillich, Pharm.D.
• 2024 - James E. Polli, Ph.D.
• 2023 - Jeffrey Aubé, Ph.D.
• 2022 - Marilyn Morris, Ph.D.
• 2021- Carston Wagner, Ph.D.
• 2020 - Kim Brouwer, Ph.D., Pharm.D.
• 2019 - Rodney Ho, Ph.D.
• 2018 - Kathleen M. Giacomini, Ph.D.
• 2017 - Palmer W. Taylor, Ph.D.
• 2016 - Julie A. Johnson, Pharm.D.
• 2015 - Kuo-Hsiung Lee, Ph.D.
• 2014 - John M. Pezzuto, Ph.D.
• 2013 - Gunda I. Georg, Ph.D.
• 2012 - Gene D. Morse, Pharm.D.
• 2011 - Sidney D. Nelson, Ph.D.
• 2010 - Hartmut C. Derendorf, Ph.D.
• 2009 - Duane D. Miller, Ph.D.

The intent of the Paul R. Dawson Award for Excellence in Patient Care Research is to recognize annually an active scientist within the ranks of pharmacy education as a leader in the broad range of research related to health services delivery directly affecting patient outcomes, including basic, clinical, translational and health services research. Since 2015, the award criteria include all research that has made sustained contributions to the quality of patient outcomes. This award consists of a glass sculpture and complimentary registration to the AACP Annual Meeting.  The award was endowed by Amgen in honor of its former Vice President of Marketing and Sales Paul R. Dawson.

Applications for the Paul R. Dawson Award for Excellence in Patient Care Research are due by 11:59 p.m. PST on Monday, December 1, 2025. Visit the application site to begin the submission process.

ELIGIBILITY

1. Nominees must hold a faculty appointment with a primary commitment to an AACP member college or school of pharmacy or be within five years of their full retirement from a faculty appointment.
2. Nominees must be members of AACP, and have shown a commitment to the Association and mission and objectives of pharmacy education. A nominee’s name may not be submitted posthumously.
3. Nominees will be evaluated based on contributions to contemporary teaching and research that have made sustained contributions to the quality of patient outcomes.
   • Research and Scholarly Activities: research and creative scholarship relative to the quality of patient outcomes that can be documented in terms of publications (number and type) and grants/contracts.
   • Instruction: including, but not limited to, effectiveness in professional and/or graduate instruction; curriculum development and innovation; accomplishments of former students; and honors and awards for excellence in teaching related to the quality of patient outcomes. Contributions beyond the local college level are considered particularly important.
   • Other Contributions: activities and recognitions of a varied nature that have a documented impact on the quality of patient outcomes.

AACP's AWARDS AND NOMINATIONS POLICY

Disclosure Required

AACP’s Board of Directors has adopted a policy affirming AACP’s right to grant, defer or decline to grant an honor or award, including a leadership position, to any person. AACP expects all recipients of honors and awards to embody the highest standards of professional and personal ethical behavior, therefore, AACP will not confer any honor, award or leadership position when, in its discretion, there has been a determination or credible question of unethical behavior. 

To implement this policy, AACP is instituting a disclosure process for nominees for the Paul R. Dawson Award. The required disclosure form must be completed, signed and submitted by December 1 to disclosure@aacp.org.

NOMINATION PROCEDURE

1. Nominations may be made by any AACP member and are encouraged from faculty members of colleges and schools of pharmacy and from all segments of the Association (e.g., sections, special interest groups, affiliate members).
2. The dossier’s contents shall include:
   • Cover letter from the nominator summarizing the nominee’s qualifications and commitment to the Association;
   • Résumé detailing education, appointments, activities, memberships, awards and honors and other relevant data;
   • Contributions to scholarship in the realm of directly impacting the quality of patient outcomes;
   • Contributions to instruction in the relevant area; and
   • An additional three to five letters of support, including those endorsements from individuals outside of the nominee’s home institution (supporting letters should interpret the impact that the nominee has had on his/her field and pharmacy education).
3. The dossier should be submitted online by 11:59 p.m. PST on the date of the submission deadline. Materials will then be reviewed by the selection committee once an initial screening is completed.

SELECTION PROCEDURE

1. Dossiers will be screened for completeness by staff upon receipt. If time permits, staff will notify nominators of missing items. Applications that are incomplete at the deadline for submission will not be evaluated.
2. A Paul R. Dawson Award Committee appointed by the AACP president will conduct peer review of nominations in light of the established criteria for the Award.
3. At the conclusion of the evaluation process, the committee will forward one name to the AACP Board of Directors for ratification at its February meeting. In addition, the award committee shall provide to the Board of Directors a short justification for the selected award recipient. The committee may recommend that the Award not be presented in any given year.

Please contact Adam Jackson, Director of Governance, with any questions.

Past Award Recipients

2025 - C. Daniel Mullins, Ph.D.

2024 - M. Lynn Crismon, Pharm.D.

2023 - Sandra Kane-Gill, Pharm.D.

2022 - Rajender Aparasu, Ph.D.

2021 - William Doucette, Ph.D.

2020 - Betty Chewning, Ph.D.

2019 - Karen S. Hudmon, Dr. P.H. 

2018 - S. Suresh Madhavan, Ph.D.

2017 - Eric W. Schmidt, Ph.D.

2016 - Albert I. Wertheimer, Ph.D.

2015 - Marie A. Chisholm-Burns, Pharm.D., M.P.H., MBA

2014 - Anil Gulati, M.D., Ph.D.

2013 - Alexander S. Mankin, Ph.D.

2012 - Tejal A. Desai, Ph.D.

2010 - Harold L. Kohn, Ph.D.

2009 - Rodney J. Ho, Ph.D.

2008 - Laurence H. Hurley, Ph.D.

The Lifetime Achievement Award consists of a sculpture/plaque. This Award recognizes and promotes individuals who have made a significant contribution to the American Association of Colleges of Pharmacy and to pharmacy education through instruction, leadership/service and research/scholarship over a minimum of 25 years.

ELIGIBILITY

1. Nominees must hold a faculty appointment with a primary commitment to an AACP member college or school of pharmacy or be retired from a faculty appointment.
2. Nominees must be members of AACP, and have shown a commitment to the Association and mission and objectives of pharmacy education. A nominee’s name may not be submitted posthumously.
3. Nominees will be evaluated based upon contributions in the following areas:
   • Instruction including, but not limited to, effectiveness in undergraduate, postbaccalaureate, professional and graduate instruction; curriculum development and innovation; accomplishments of former students; special student educational projects; honors and awards for excellence in teaching and invited lectureships; and assessment of national educational involvement including active participation in AACP meetings, committees, teachers seminars and national workshops. Among the most important qualities are inspiration, leadership and quality of contributions and the impact on educational programs and professional growth of individuals;
   • Advancement of the profession of pharmacy, can be documented in terms of the following examples but not limited to: contributing to the development of the ACPE Standards, transforming the delivery of pedagogy, serving at the forefront of technology and/or innovation, advancing interprofessional education, significant contributions in pharmacy education administration that lead to improved patient outcomes and or improvements in pharmacy education, creating new knowledge such as, a pharmaceutical science discovery that enhances drug therapy for improved patient outcomes, or developing new care delivery models that improve patient outcomes, or developing patient interventions that improve outcomes, and modeled excellence of pharmacy;
   • Leadership/Service to AACP: Sustained service/leadership to with American Association of Colleges of Pharmacy (consideration should be given to the breadth of service to AACP elected and all other forms of volunteer service).
   • Leadership/Service on behalf of Academic Pharmacy: Sustained contributions externally on behalf of academic pharmacy, outside of AACP and one's own institution, such as but not limited to active involvement in local, state and/or national pharmacy organizations and other health-related organizations through elected office, committee participation and contributions to program development; and
   • Evidence of research and creative scholarship activities relative to the respective discipline and/or to the quality of patient outcomes that can be documented in terms of publications (number and type) and grants/contracts.

AACP's AWARDS AND NOMINATIONS POLICY

Disclosure Required

AACP’s Board of Directors has adopted a policy affirming AACP’s right to grant, defer or decline to grant an honor or award, including a leadership position, to any person. AACP expects all recipients of honors and awards to embody the highest standards of professional and personal ethical behavior, therefore, AACP will not confer any honor, award or leadership position when, in its discretion, there has been a determination or credible question of unethical behavior. 

To implement this policy, AACP is instituting a disclosure process for nominees for the Lifetime Achievement Award. The required disclosure form must be completed, signed and submitted by the submission deadline to disclosure@aacp.org.

NOMINATION PROCEDURE

1. Nominations will be brought forth by members of the Board of Directors, but recommendations may be made by any AACP member, including self-nominations and are encouraged from faculty members of colleges and schools of pharmacy and from all segments of the Association (e.g., sections, special interest groups, affiliate members).
2. Any AACP member intending to recommend a nomination must submit a dossier received by the submission deadline. The dossier’s contents shall be presented to include the following separate sections, each beginning on a new page:
   • Cover letter from the nominator summarizing the nominee’s qualifications and commitment to the Association;
   • Résumé (CV) detailing education, appointments, activities, memberships, awards and honors, and other relevant data;
   • Reflection on contributions to instruction;
   • Reflection on contributions to the advancement of the profession of pharmacy;
   • Reflection on contributions to leadership/service to Association, local, state and/or national pharmacy organizations and other health-related organizations;
   • Reflection on evidence of research and creative scholarship activities; and
   • An additional three to five letters of support with reflections on the nominee’s contributions including those endorsements from individuals outside of the nominee’s home institution (supporting letters should interpret the impact that the nominee has had on his/her field and pharmacy education and provide evidence of contributions to instruction, to the advancement of the profession of pharmacy, leadership/service, and evidence of research and creative scholarship activities).
3. The dossier should be submitted by email by 11:59 p.m. PST on Monday, December 1, 2025. Materials will be reviewed by the Board of Directors during their meeting in February after a screening for completeness by AACP Staff.

Recommendations of nominations or questions regarding the nomination or submission process should be directed to Adam Jackson, AACP Director of Governance .

SELECTION PROCEDURE

1. Dossiers will be screened for completeness by staff upon receipt. If time permits, staff will notify nominators of missing items. Applications that are incomplete at the deadline for submission will not be evaluated.
2. The AACP Board of Directors will serve as the Lifetime Achievement Award Selection Committee and will conduct peer review of nominations in light of the established criteria for the award.
3. At the conclusion of the evaluation process, the AACP Board of Directors will select and notify a single recipient.
4. The AACP Board of Directors will present this Award based on qualified applicants only and reserves the right not to present the Award on an annual basis.

 

The Lifetime Achievement Award recognizes and promotes individuals who have made a significant contribution to the American Association of Colleges of Pharmacy and to pharmacy education through instruction, leadership/service and research/scholarship over a minimum of 25 years.

Please contact Adam Jackson, AACP Director of Governance with any questions.

The award winner will be announced by the AACP Board of Directors in the spring and published in AACP E-lert and on the website. They will also be honored during the Annual Meeting.

Please view the Award Information and Nomination Instructions.

Applications for the 2026 Lifetime Achievement Award are due by 11:59 p.m. PST on Monday, December 1, 2025.

Past Award Recipients

2025 - Brian Erstad

2024 - Barbara Wells, Pharm.D.,

2022 - Marilyn K. Speedie, Ph.D.

2021 - Victoria F. Roche, Ph.D.

2020 - No recipient 

2019 - JoLaine R. Draugalis, R.Ph., Ph.D. 

2018 - Milap C. Nahata, PharmD

2017 - Nicholas G. Popovich, Ph.D.

Program and Abstract Submissions

This page provides information about the different types of presentations and announcements that members can submit for inclusion in the AACP Annual Meeting. Specific information about various submission types and their associated deadlines can be found below. AACP members will submit school posters, annual meeting programming proposals, research and education poster abstracts through the submission portals in the Cadmium Abstract Scorecard.